The Ledger

CAH

Cardinal Health IncHealth Careinsider_universe

Last close $240.22Jun 28, 2026

Day +0.97%

Currently held

Agent 20 — SIR Price/Volumelong
9 sh @ $216.30 · stop $204.93
+$171.00 unrealized
Agent 8 — Dip Buyer (Peer-Aware)long
5 sh @ $201.14 · stop $179.58
+$170.78 unrealized

Everything we've seen

·Jun 29, 3:47 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 3:47 PMstreamnews
Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade)
Cardinal Health has experienced a significant surge in share price, surpassing initial expectations. Check out why CAH stock is downgraded to a hold.
·Jun 29, 3:47 PMstreamnews
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often
·Jun 29, 3:33 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 3:33 PMstreamnews
Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade)
Cardinal Health has experienced a significant surge in share price, surpassing initial expectations. Check out why CAH stock is downgraded to a hold.
·Jun 29, 3:20 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 3:20 PMstreamnews
Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade)
Cardinal Health has experienced a significant surge in share price, surpassing initial expectations. Check out why CAH stock is downgraded to a hold.
·Jun 29, 3:05 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 3:05 PMstreamnews
Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade)
Cardinal Health has experienced a significant surge in share price, surpassing initial expectations. Check out why CAH stock is downgraded to a hold.
·Jun 29, 2:50 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 2:50 PMstreamnews
Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade)
Cardinal Health has experienced a significant surge in share price, surpassing initial expectations. Check out why CAH stock is downgraded to a hold.
·Jun 29, 2:35 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 2:35 PMstreamnews
Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade)
Cardinal Health has experienced a significant surge in share price, surpassing initial expectations. Check out why CAH stock is downgraded to a hold.
·Jun 29, 2:20 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 2:05 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 1:50 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 1:35 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 1:20 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 1:04 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 12:49 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 12:34 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 12:19 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 12:04 PMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 11:49 AMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 11:34 AMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 11:19 AMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 11:04 AMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 10:49 AMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
·Jun 29, 10:34 AMstreamnews
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
!Jun 29, 9:51 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 29, 7:06 AMsignal
Agent 6 — Options Momentum — insufficient_capital
❖Jun 29, 1:02 AMnewsvia finnhub
Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade)
Cardinal Health has experienced a significant surge in share price, surpassing initial expectations. Check out why CAH stock is downgraded to a hold.
❖Jun 27, 2:28 AMnewsvia finnhub
Best Dividend Aristocrats: June 2026
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
❖Jun 26, 6:00 PMnewsvia finnhub
Why the Market Dipped But Cardinal Health (CAH) Gained Today
Cardinal Health (CAH) closed at $237.92 in the latest trading session, marking a +1.35% move from the prior day.
❖Jun 26, 1:55 PMnewsvia finnhub
Dividend Champion, Contender, And Challenger Highlights: Week Of June 28
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read it here.
!Jun 26, 12:49 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 11:51 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 10:48 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 10:35 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 10:21 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 9:50 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 9:35 AMsignal
Agent 6 — Options Momentum — insufficient_capital
❖Jun 26, 5:20 AMnewsvia finnhub
2 Large-Cap Stocks Worth Your Attention and 1 We Brush Off
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
❖Jun 25, 5:15 PMnewsvia finnhub
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?
AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and valuation metrics.
❖Jun 25, 9:40 AMnewsvia finnhub
Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?
Here is how Bayer Aktiengesellschaft (BAYRY) and Cardinal Health (CAH) have performed compared to their sector so far this year.
❖Jun 25, 9:15 AMnewsvia finnhub
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
❖Jun 24, 9:52 PMnewsvia finnhub
Dow Jones Futures: Micron Earnings Send Sandisk, Techs Soaring; Fed Inflation Data Due
Micron surged overnight on strong earnings and guidance, lifting other memory and chip plays. The Fed's favorite inflation gauge is on tap.
❖Jun 24, 6:15 PMnewsvia finnhub
Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Cardinal Health (CAH) closed at $233.01, marking a +1.79% move from the previous day.
❖Jun 24, 5:50 PMnewsvia finnhub
Dow Jones Futures Rise As Micron Jumps On Earnings, Lifting Sandisk, AI Stocks; Fed Inflation Data Due
Micron surged overnight on strong earnings and guidance, lifting other memory and chip plays. The Fed's favorite inflation gauge is on tap.
❖Jun 24, 9:30 AMnewsvia finnhub
[Latest] Global Neonatal Intensive Care Respiratory Devices Market Size/Share Worth USD 5.7 Billion by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Neonatal Intensive Care Respiratory Devices Market size & share revenue was valued at approximately USD 2.1 Billion in 2025 and is expected to reach USD 2.3 Billion in 2026 and is expected to reach around USD 5.7 Billion by 2035, at a CAGR of 10.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Inspirat
❖Jun 23, 7:53 PMnewsvia finnhub
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate industry headwinds.
❖Jun 20, 4:08 PMnewsvia finnhub
Cardinal Health (CAH) Stock Could Be 9.6% Undervalued Despite Rich P/E Signals
Cardinal Health (CAH) has drawn investor attention after its stock closed at $221.77. This has put recent performance and current valuation metrics in focus for those tracking large U.S. healthcare distributors. See our latest analysis for Cardinal Health. While Cardinal Health’s share price slipped around 2% in the latest session, the 30-day share price return of 10.55% and 1-year total shareholder return of 37.25% sit alongside a very large 5-year total shareholder return of 334.47%. Taken...
❖Jun 19, 1:10 PMnewsvia finnhub
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?
Amgen posts strong profits and cash flow, while NovoCure pursues growth with a direct-to-patient cancer therapy model and leaner balance sheet.
❖Jun 19, 8:36 AMnewsvia finnhub
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?
Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.
❖Jun 18, 6:00 PMnewsvia finnhub
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Cardinal Health (CAH) stood at $221.77, denoting a -1.99% move from the preceding trading day.
❖Jun 18, 1:30 PMnewsvia finnhub
Global Closed System Drug Transfer Devices Market Size/Share Worth USD 3.21 Billion by 2035 at a 8.3% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Closed System Drug Transfer Devices Market size & share revenue was valued at approximately USD 1.47 Billion in 2025 and is expected to reach USD 1.58 Billion in 2026 and is expected to reach around USD 3.21 Billion by 2035, at a CAGR of 8.3% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are BD (Becton Dic
❖Jun 18, 12:49 PMnewsvia finnhub
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?
COR shares are down 18% YTD, but rising EPS guidance, specialty pharma growth and strategic expansion could make this pullback worth watching.
?Jun 18, 11:10 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
CAH is down 2.58% intraday, a meaningful move suggesting real selling pressure. The single headline referencing 'headwinds' is directionally consistent with the move but provides limited additional catalyst. Macro context shows a flat/slightly positive yield curve (T10Y2Y at 0.29, below trend), which mildly favors defensives like healthcare distributors — this could act as a modest headwind to further downside but is not a strong reversal signal. With 275 minutes remaining there is ample time for continuation, but also for mean-reversion. No strong technical reversal pattern is described. The setup is ordinary momentum with no compelling reason to expect a fade, but also lacks the clear volume/sector confirmation needed for high conviction. Assigning a modest continuation probability just above the threshold.
!Jun 18, 11:10 AMsignalseverity -0.03
Agent 7 — Day Trader — day_trade_skipped
CAH is down 2.58% intraday, a meaningful move suggesting real selling pressure. The single headline referencing 'headwinds' is directionally consistent with the move but provides limited additional catalyst. Macro context shows a flat/slightly positive yield curve (T10Y2Y at 0.29, below trend), which mildly favors defensives like healthcare distributors — this could act as a modest headwind to further downside but is not a strong reversal signal. With 275 minutes remaining there is ample time for continuation, but also for mean-reversion. No strong technical reversal pattern is described. The setup is ordinary momentum with no compelling reason to expect a fade, but also lacks the clear volume/sector confirmation needed for high conviction. Assigning a modest continuation probability just above the threshold.
❖Jun 18, 9:30 AMnewsvia finnhub
Is It Worth Investing in Cardinal (CAH) Based on Wall Street's Bullish Views?
Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
❖Jun 18, 9:17 AMnewsvia finnhub
1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
!Jun 17, 3:47 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 3:18 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 2:47 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 2:33 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 2:17 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 1:48 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 1:34 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 1:18 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 12:47 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 12:33 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 12:18 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 11:46 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 11:34 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 10:18 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 10:06 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 9:47 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 9:16 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 9:02 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 17, 7:02 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 16, 5:45 PMsignal
Agent 6 — Options Momentum — insufficient_capital
❖Jun 16, 2:14 PMnewsvia finnhub
Reasons to Retain Baxter International Stock in Your Portfolio for Now
BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.
❖Jun 16, 9:54 AMnewsvia finnhub
Here's Why You Should Retain BDX Stock in Your Portfolio Now
Becton, Dickinson's MedTech focus, innovation push and strategic partnerships support growth optimism, though reimbursement uncertainty remains a key concern.
❖Jun 15, 11:47 AMnewsvia finnhub
Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?
Cardinal Health has outperformed the healthcare sector over the past year. Moreover, Wall Street analysts are strongly bullish on the stock.
❖Jun 15, 4:51 AMnewsvia finnhub
Top 3 Health Care Stocks That May Collapse This Quarter
3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, but positive price action for TGTX.
▣Jun 14, 8:00 PMjournaltarget
Agent 5 — Dip Buyer (Evolving) closed long 1 @ $226.38 (+$32.00)
Target hit (partial-rounded-to-full): close $226.38 ≥ target $217.77
▣Jun 14, 8:00 PMjournalmanual
Agent 5 — Dip Buyer (Evolving) closed long 1 @ $222.47 (+$28.09)
Staged exit (1/2.0): close $223.85 ≥ target $217.77. Selling 1/2 sh, trailing remainder.
❖Jun 12, 1:16 PMnewsvia finnhub
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Stryker faces cyberattack fallout, but strong procedure demand, record Mako adoption and global expansion continue to support long-term growth.
❖Jun 12, 9:40 AMnewsvia finnhub
Is Cardinal Health (CAH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
▣Jun 11, 8:00 PMjournalmanual
Agent 5 — Dip Buyer (Evolving) closed long 1 @ $217.49 (+$23.11)
Staged exit (1/2.0): close $221.16 ≥ target $217.77. Selling 1/3 sh, trailing remainder.
✓Jun 10, 8:31 PMdecisionacted
Agent 20 — SIR Price/Volume — buy
[cluster_break_up] The PV path shows a textbook cluster_break_up setup. From 2026-05-21 through 2026-06-05, CAH's scatter dots clustered tightly in the $194–$202 price band on declining or subdued volume (1.2M–2.3M), forming a clear low-energy consolidation base. The break begins on 2026-06-09 when the close surged to $212.67 on 3.2M volume — the highest up-day volume in over two weeks — and is confirmed on 2026-06-10 (today) with a follow-through close at $216.30 on 3.4M volume (z-score +1.55 vs. trailing 20-day mean of 2.3M). Two consecutive expanding-volume up-days clearing the cluster by ~7% satisfies SIR's multi-session confirmation requirement; the path has moved decisively up-and-right out of the base, signaling fresh demand absorbing the float rather than a single-bar anomaly. Risks: A reversal back below the cluster ceiling (~$202) on elevated volume would signal a failed breakout and distribution, invalidating the bullish read entirely. Additionally, the macro backdrop — T10Y2Y at 0.4 (2.1σ below trend) flagging a bear-flattening yield curve — poses a sector-level headwind for Health Care defensives if risk-off rotation accelerates and compresses multiples.
▣Jun 10, 8:00 PMjournaltarget
Agent 5 — Dip Buyer (Evolving) closed long 3 @ $221.16 (+$80.34)
Staged exit (1/2.0): close $221.16 ≥ target $217.77. Selling 3/6 sh, trailing remainder.
▣Jun 10, 8:00 PMjournaltarget
Agent 8 — Dip Buyer (Peer-Aware) closed long 5 @ $221.16 (+$100.08)
Staged exit (1/2.0): close $221.16 ≥ target $217.77. Selling 5/10 sh, trailing remainder.
?Jun 10, 11:26 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
CAH is up 2.83% intraday with no attributable headline, suggesting institutional flow rather than news-driven speculation. With 260 minutes remaining (well over 4 hours), there is ample time for continuation into the close. However, the macro context is a mild headwind: T10Y2Y at 2.1σ below trend favors defensive sectors in a bear-flattening environment, and CAH as a healthcare distributor (defensive) could see some rotation pressure if the yield curve dynamic is actively being traded today. No reversal signal is evident from the data provided — the move appears to be holding. Absence of news is not a disqualifier; the 2.83% move itself represents meaningful conviction. With no clear fade catalyst and time remaining sufficient for trend continuation, a modest continuation probability above 0.5 is appropriate, though the muted macro tailwind and lack of confirmatory volume data prevent a higher conviction read.
✓Jun 10, 9:36 AMdecisionacted
Agent 8 — Dip Buyer (Peer-Aware) — pyramid
Pyramid add-on fired at +10.15% unrealized. Added 3 sh @ $215.01 ($645.04). Position now 10 sh @ weighted avg $201.14.
❖Jun 9, 11:05 AMnewsvia finnhub
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora are two of the best healthcare buys right now.
❖Jun 8, 1:12 PMnewsvia finnhub
Tris Pharma Introduces a New 60 mL Bottle Size for DYANAVEL® XR (amphetamine) Extended-Release Oral Suspension CII
A new, smaller 60 mL bottle brings pharmacy-stocking and dosing convenience to a once-daily liquid amphetamine designed for individualized titration in ADHDMONMOUTH JUNCTION, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company advancing transformative targeted CNS therapeutics, today announced the availability of DYANAVEL® XR (amphetamine) extended-release oral suspension, CII (2.5 mg/mL) in a new, smaller 60 mL bottle (NDC 24478-102-02)
❖Jun 6, 2:11 AMnewsvia finnhub
How The Mixed Analyst Calls Are Reframing The Cardinal Health (CAH) Investment Story
Cardinal Health is back in focus as fresh Street research reshapes the price target conversation, with several firms trimming their targets while one raises its view and another starts coverage on a bullish footing. Those mixed calls reflect a split between analysts who see room for upside if execution holds and others who are more cautious about how much to pay for the stock right now. As you read on, you will see how to track these shifting views and what they might mean for your own...
❖Jun 5, 7:00 PMnewsvia finnhub
Why Coca-Cola and Walmart Top This List of Steady, Low-Volatility Dividend Aristocrats
Dividend Aristocrats can offer income, stability, and consistency. Here are four lower-volatility names analysts still like.
?Jun 5, 3:31 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
CAH is up 1.77% intraday, a modest but real move. However, with only 15 minutes remaining until the forced close, there is very little time for additional upside to develop toward the +3% target. The macro context shows a flattening yield curve (T10Y2Y 1.9σ below trend), which is a mild headwind for defensives like healthcare distributors in a bear-flattening environment. No news catalyst is present to sustain buying pressure. With the extreme time constraint, even a genuine momentum setup has insufficient runway to reach the profit target before the 3:45 PM ET cutoff, and late-session profit-taking is a common pattern for stocks already up ~2% without a clear catalyst. The risk/reward of entering with 15 minutes left is unfavorable — the probability of meaningful continuation in this window falls below the 0.5 threshold.
?Jun 5, 9:20 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
CAH is up 3.01% intraday with no headline catalyst visible, suggesting institutional flow or sector rotation rather than a news spike that might fade quickly. With 385 minutes remaining (well over 6 hours — this appears to be an early-session read), there is ample time for continuation. However, the macro context is a mild headwind: the T10Y2Y spread printing 1.9σ below trend favors defensives in a bear-flattening scenario, and CAH (healthcare distribution) is a defensive name that could see some of today's move attributed to defensive rotation — which may already be largely priced in at this intraday level. The absence of news means we cannot confirm a fundamental catalyst, but per framework this does not disqualify the setup. The 3% move represents real size and conviction. No reversal pattern or fade signal is evident. With no strong reason to expect a fade but also no clear continuation catalyst beyond price momentum, this sits in the ordinary momentum band. Assigning 0.54 — lean long but not high conviction.
❖Jun 4, 4:32 PMnewsvia finnhub
Stocks Rebound on Strength in Banks and Managed Healthcare
The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.41%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +1.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.53%. June E-mini S&P futures (ESM26 ) rose +0.36%, and June E-mini Nasdaq futures...
?Jun 4, 2:00 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
CAH is up 2.82% intraday, a meaningful move suggesting real institutional flow with conviction. No directly attributable headline for CAH today (the Kinaxis headline is irrelevant), but absence of news does not disqualify continuation. Macro context is mildly cautious — T10Y2Y at 2.1σ below trend favors defensives in a bear-flattening regime, and CAH (healthcare distribution) has some defensive characteristics that could be supportive rather than headwind. However, with 105 minutes remaining, the move is already well-developed at nearly 3% and approaching the +3% profit target zone (~$201.74 from prior close), which may invite profit-taking and natural resistance. The macro yield curve read is not a strong tailwind for this specific name. Overall, no clear reason to fade — momentum bias holds — but limited upside remaining to the target and moderate time left temper conviction. Assigning a modest continuation probability just above threshold.
❖Jun 4, 11:30 AMnewsvia finnhub
Dentsply (XRAY) Down 13.5% Since Last Earnings Report: Can It Rebound?
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
❖Jun 4, 11:16 AMnewsvia finnhub
Stocks Mixed as Tech Weakness Weighs
The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.90%. June E-mini S&P futures (ESM26 ) are up +0.02%, and June E-mini Nasdaq futures...
❖Jun 4, 7:00 AMnewsvia finnhub
Kinaxis Unveils 2026 Customer Award Winners at Kinexions in Las Vegas
LAS VEGAS, June 04, 2026--Kinaxis® (TSX: KXS), a global leader in end-to-end supply chain planning and orchestration, today announced the winners of its 2026 Customer Awards. Now in their eighth year, these awards were celebrated live at Kinexions North America, the flagship premiere global conference hosted by Kinaxis, bringing together supply chain leaders from around the world.
❖Jun 2, 5:41 AMnewsvia finnhub
3 Market-Beating Stocks with Exciting Potential
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.
❖Jun 2, 4:18 AMnewsvia finnhub
Nuclear Medicine Market by Type, Application, Procedure, End User, and Region - Global Forecast to 2030
The global nuclear medicine market is set to expand from USD 10.41 billion in 2025 to USD 21.01 billion by 2030, boasting a CAGR of 15.1%. This robust growth is fueled by heightened demand for diagnostic and therapeutic radiopharmaceuticals in oncology, cardiology, and neurology. Hospitals are projected to dominate the market share, while therapeutic applications will outpace diagnostics. Asia Pacific is expected to exhibit the fastest regional growth. Key players include GE HealthCare, Cardinal
❖Jun 1, 2:39 PMnewsvia finnhub
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie and Pfizer chart distinct paths in revenue growth, risk, and valuation. Explore how their financials and strategies stack up for investors this year.
❖Jun 1, 9:55 AMnewsvia finnhub
Wall Street Analysts Predict a 25.75% Upside in Cardinal (CAH): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 25.8% in Cardinal (CAH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
▣May 28, 8:00 PMjournalstop
Agent 6 — Options Momentum closed long 100 @ $5.35 (-$260.20)
Stop: premium $5.35 ≤ trailing floor $6.38 (peak $8.51 × 0.75)
❖May 28, 4:30 AMnewsvia finnhub
You've Got To Take 'These Gifts' – Jim Cramer Says You Should Buy These 6 Stocks Amid 'So Much Opportunity'
❖May 27, 9:45 AMnewsvia finnhub
2 S&P 500 Stocks to Target This Week and 1 We Brush Off
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
❖May 27, 9:40 AMnewsvia finnhub
Is Cardinal Health (CAH) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
❖May 27, 9:30 AMnewsvia finnhub
Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Cardinal (CAH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
❖May 27, 4:43 AMnewsvia finnhub
Best Dividend Aristocrats: May 2026
The Dividend Aristocrats underperformed SPY YTD, returning 3.34% versus SPY's 10.39%, though 22 Aristocrats still posted double-digit gains.
❖May 26, 9:14 AMnewsvia finnhub
Cardinal Health (CAH) Valuation Check After Recent Sideways Share Performance
Recent performance snapshot for Cardinal Health (CAH) Cardinal Health (CAH) has moved largely sideways in the short term, with the stock close to flat over the past day and week, and a small gain over the past month. Over the past 3 months, the share price is down about 11%, while the year to date return shows a decline of roughly 2%. Looking further back, the 1 year total return is about 31%, with multi year total returns that are much higher. These mixed returns come alongside reported...
❖May 25, 11:15 AMnewsvia finnhub
Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?
CAH's fast-growing Other Growth Businesses posted 34% revenue growth and 52% profit gains, raising their role in long-term earnings.
❖May 23, 6:20 AMnewsvia finnhub
1 of Wall Street’s Favorite Stock with Competitive Advantages and 2 We Find Risky
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
✓May 20, 6:00 PMdecisionacted
Agent 6 — Options Momentum — decide: buy
CALL on CAH — 5-day return 6.93% with close above 20-day MA ($194.92). IV 34.9%. Sized 1 contract(s) at $7.95 premium.
✓May 20, 7:00 AMdecisionacted
Agent 6 — Options Momentum — decide: buy
CALL on CAH — 5-day return 9.76% with close above 20-day MA ($194.98). IV 35.6%. Sized 1 contract(s) at $8.71 premium.
▢May 19, 8:00 PMjournal
Agent 6 — Options Momentum opened long 100 @ $7.95
?May 19, 2:21 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
CAH is up 1.52% today, a modest but real move suggesting some directional flow. No headlines are available to explain the move, which is common — absence of news is not disqualifying. However, several factors temper conviction: (1) The move is only 1.52%, below the 2-5% threshold that would signal strong institutional conviction or a catalyst-driven run. (2) With 85 minutes remaining until the 3:45 PM cutoff, there is time for continuation but also meaningful risk of afternoon fade, particularly in a low-news environment where the initial push may have exhausted near-term buyers. (3) The macro context shows elevated 10-year inflation expectations (T10YIE at 2.4σ above trend), which pressures long-duration sensitive sectors; CAH as a healthcare distributor is not highly duration-sensitive, so this is a modest headwind rather than a direct negative. (4) No reversal signals or fade patterns are evident from the data provided. On balance, the modest upward momentum with no counter-thesis warrants a slight lean toward continuation per the system's borderline-favor-action rule, but this is a low-conviction read.
?May 19, 12:50 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
CAH is up 1.67% today, a modest but real move suggesting some buying conviction. No news headlines are available to explain the move, which is common and not disqualifying. The macro context shows elevated 10-year inflation expectations (T10YIE at 2.4σ above trend), which is a mild headwind for long-duration sensitive sectors, but CAH as a healthcare distributor is relatively rate-insensitive and not in the primary crosshairs of that dynamic. With 175 minutes remaining there is meaningful time for continuation, but the move is below the 2% threshold where momentum becomes strongly self-reinforcing. No reversal signals or thin-volume flags are evident from the data provided. Overall this is a borderline read — modest momentum, neutral-to-mild macro backdrop, ample time — that resolves just above the 0.5 threshold per the system's bias toward action when no clear fade reason exists.
?May 19, 11:01 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
CAH is up 1.68% with no attributable headline, suggesting quiet institutional flow rather than a news-driven spike that might fade. The move is below the 2-5% threshold for strong conviction reads, so it's a modest drift upward. Macro context shows elevated 10Y inflation expectations (2.4σ above trend), which is a mild headwind for long-duration sensitive sectors, but CAH as a healthcare distributor is relatively insensitive to duration dynamics — this macro factor is largely neutral here. With 285 minutes remaining there is ample time for continuation or mean reversion. No reversal signal or fade pattern is evident from the data provided. The absence of news does not argue against continuation. Base case is mild upward drift persists into close, but conviction is low given the modest move magnitude and no catalytic driver. Probability just above the 0.5 threshold reflecting ordinary momentum with no strong reason to fade.
✓May 19, 7:01 AMdecisionacted
Agent 6 — Options Momentum — decide: buy
CALL on CAH — 5-day return 9.46% with close above 20-day MA ($195.21). IV 37.0%. Sized 1 contract(s) at $8.86 premium.
✓May 18, 9:25 AMdecisionacted
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
CAH's 10.4% drop from its 30-day high appears largely sector-driven rather than company-specific — Health Care (XLV) ranks 10th of 11 sectors by 30-day relative strength with a -13.87pt underperformance vs. SPY, suggesting the dip reflects sector-wide rotation pressure rather than idiosyncratic impairment. A recent news headline references a higher dividend and raised guidance, which is a modest positive fundamental signal indicating management confidence in the business. Options flow shows a bullish-leaning P/C ratio of 0.70 with meaningful call volume (2,373 vs. 1,660 puts), suggesting more call interest than put interest on the dip. Earnings are 84 days away, well outside the binary-event caution window, removing that key risk factor.
?May 18, 8:54 AMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
With no recent news headlines or SEC filings available, there is no evidence of fundamental deterioration at Cardinal Health — the drop appears likely attributable to macro-driven sector rotation or broader market pressure rather than company-specific issues. The elevated 5-year inflation breakeven (2.7, ~2.5σ above trend) suggests a risk-off or rate-anxiety environment that could weigh on defensive healthcare distributors with thin margins. CAH is a large, established pharmaceutical distributor with historically stable cash flows, so the business itself appears sound absent contrary evidence.
▢May 17, 8:00 PMjournal
Agent 8 — Dip Buyer (Peer-Aware) opened long 5 @ $201.14
❖May 17, 5:03 PMnewsvia finnhub
What Lone Peak’s $20 Million Thermon Exit Could Signal After Record Earnings
Thermon Group delivers industrial heating solutions worldwide, serving sectors from energy and transit to tech and manufacturing.
❖May 17, 9:38 AMnewsvia finnhub
Kiplinger’s May 2026 Letter Says Yields From 3% to 13% Are Available Right Now Despite Iran War Uncertainty
Kiplinger’s Personal Finance May 2026 letter makes it clear that if you are looking for yield, the door is wide open across the entire risk spectrum. We are seeing a massive spread, with opportunities ranging from stable 3% municipal bonds to 13% for those willing to get aggressive with business development companies. This is unfolding ... Kiplinger’s May 2026 Letter Says Yields From 3% to 13% Are Available Right Now Despite Iran War Uncertainty
?May 16, 6:35 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $6.08 cash available; close=$195.20.
?May 16, 10:05 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
CAH is down 10.4% from its 30-day high at $195.20, but the evidence base is nearly empty — no recent news, no SEC filings, no insider activity, and no options flow data to diagnose the cause of the decline or signal informed buying interest. Without understanding why the stock dropped, buying into the dip carries unquantified idiosyncratic risk. The macro backdrop is mixed but not supportive: today's broad market is under pressure (SPY -1.20%, IWM -2.41%), the 10Y yield at 4.47% is near the structural headwind threshold, and the 5Y breakeven inflation at 2.7% (2.5σ above trend) introduces macro uncertainty that weighs on rate-sensitive healthcare distributors. VIX at the 50th percentile is neutral — not elevated enough to signal a capitulation bottom, but not benign either. Earnings are 86 days out, which removes binary event risk from the 90-day window. However, without any confirming signals (no insider buys, no unusual call flow, no sector-underperformance context to explain a sympathy move), the drop looks unexplained and potentially fundamental. The absence of data is itself a risk factor — it prevents conviction in either direction but biases toward caution given the conservative framework.
?May 16, 9:00 AMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
With no recent news headlines or SEC filings available, there is no evidence of fundamental deterioration at Cardinal Health — the drop appears likely attributable to macro-driven sector rotation or broader market pressure rather than company-specific issues. The elevated 5-year inflation breakeven (2.7, ~2.5σ above trend) suggests a risk-off or rate-anxiety environment that could weigh on defensive healthcare distributors with thin margins. CAH is a large, established pharmaceutical distributor with historically stable cash flows, so the business itself appears sound absent contrary evidence.
?May 16, 8:58 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
CAH (Cardinal Health) is a large-cap healthcare distribution company with generally stable fundamentals, but the 10.7% drop from its 30-day high is notable given the absence of any news headlines or recent SEC filings to explain it — this suggests either sector rotation, macro-driven selling, or a catalyst that predates the 30-day window. Today's broad-market tone is constructively bullish (SPY +0.79%, VXX -2.54%), which is modestly supportive of a recovery, but the idiosyncratic nature of a ~11% drawdown without visible news is a yellow flag. The elevated 5-year inflation breakeven (T5YIE at 2.5σ above trend) adds margin pressure uncertainty for a low-margin distributor like CAH.
❖May 16, 3:16 AMnewsvia finnhub
Does Cardinal Health's (CAH) Higher Dividend and Guidance Hint at a New Capital Allocation Play?
Earlier this month, Cardinal Health, Inc. declared a quarterly dividend of US$0.5158 per share, payable on July 15, 2026, to shareholders of record as of July 1, 2026. This dividend move comes alongside upgraded fiscal 2026 earnings guidance and strong momentum in the Pharmaceutical & Specialty Solutions segment, especially specialty therapies. We’ll now examine how Cardinal Health’s raised fiscal 2026 earnings guidance may affect its investment narrative and longer-term business...
?May 15, 6:37 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
CAH (Cardinal Health) is a large-cap healthcare distribution company with generally stable fundamentals, but the 10.7% drop from its 30-day high is notable given the absence of any news headlines or recent SEC filings to explain it — this suggests either sector rotation, macro-driven selling, or a catalyst that predates the 30-day window. Today's broad-market tone is constructively bullish (SPY +0.79%, VXX -2.54%), which is modestly supportive of a recovery, but the idiosyncratic nature of a ~11% drawdown without visible news is a yellow flag. The elevated 5-year inflation breakeven (T5YIE at 2.5σ above trend) adds margin pressure uncertainty for a low-margin distributor like CAH.
?May 15, 6:33 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
CAH (Cardinal Health) is a large-cap healthcare distribution company with generally stable fundamentals, but the 10.7% drop from its 30-day high is notable given the absence of any news headlines or recent SEC filings to explain it — this suggests either sector rotation, macro-driven selling, or a catalyst that predates the 30-day window. Today's broad-market tone is constructively bullish (SPY +0.79%, VXX -2.54%), which is modestly supportive of a recovery, but the idiosyncratic nature of a ~11% drawdown without visible news is a yellow flag. The elevated 5-year inflation breakeven (T5YIE at 2.5σ above trend) adds margin pressure uncertainty for a low-margin distributor like CAH.
?May 15, 6:24 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
CAH (Cardinal Health) is a large-cap healthcare distribution company with generally stable fundamentals, but the 10.7% drop from its 30-day high is notable given the absence of any news headlines or recent SEC filings to explain it — this suggests either sector rotation, macro-driven selling, or a catalyst that predates the 30-day window. Today's broad-market tone is constructively bullish (SPY +0.79%, VXX -2.54%), which is modestly supportive of a recovery, but the idiosyncratic nature of a ~11% drawdown without visible news is a yellow flag. The elevated 5-year inflation breakeven (T5YIE at 2.5σ above trend) adds margin pressure uncertainty for a low-margin distributor like CAH.
?May 15, 6:15 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
CAH (Cardinal Health) is a large-cap healthcare distribution company with generally stable fundamentals, but the 10.7% drop from its 30-day high is notable given the absence of any news headlines or recent SEC filings to explain it — this suggests either sector rotation, macro-driven selling, or a catalyst that predates the 30-day window. Today's broad-market tone is constructively bullish (SPY +0.79%, VXX -2.54%), which is modestly supportive of a recovery, but the idiosyncratic nature of a ~11% drawdown without visible news is a yellow flag. The elevated 5-year inflation breakeven (T5YIE at 2.5σ above trend) adds margin pressure uncertainty for a low-margin distributor like CAH.
?May 15, 3:38 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
CAH (Cardinal Health) is a large-cap healthcare distribution company with generally stable fundamentals, but the 10.7% drop from its 30-day high is notable given the absence of any news headlines or recent SEC filings to explain it — this suggests either sector rotation, macro-driven selling, or a catalyst that predates the 30-day window. Today's broad-market tone is constructively bullish (SPY +0.79%, VXX -2.54%), which is modestly supportive of a recovery, but the idiosyncratic nature of a ~11% drawdown without visible news is a yellow flag. The elevated 5-year inflation breakeven (T5YIE at 2.5σ above trend) adds margin pressure uncertainty for a low-margin distributor like CAH.
✓May 15, 9:01 AMdecisionacted
Agent 7 — Day Trader — decide: buy
CAH is up 4.31% intraday with no attributable headline, suggesting institutional flow or a catalyst not yet widely reported. A move of this magnitude reflects real conviction and size. However, several factors temper enthusiasm: (1) no news anchor means the move could be driven by a single large order that has now completed, increasing fade risk; (2) the macro context shows elevated 5Y breakeven inflation (2.7, 2.5σ above trend), which is not directly supportive of healthcare/distribution names like CAH; (3) with 405 minutes remaining (effectively a full afternoon session), there is ample time for either continuation or reversal, but also for profit-taking after a sharp gap-up move. The absence of a clear catalyst and the size of the move (near the upper bound of a single-day range) suggest some mean-reversion pressure is possible. That said, the system's asymmetric payoff structure (tight -1.5% stop vs. +3% target) and the default bias toward taking borderline trades push this to a modest continuation probability above 0.5. No reversal pattern is evident, and no sector headwind is directly applicable.
✓May 14, 9:36 PMdecisionacted
Agent 5 — Dip Buyer (Evolving) — decide: buy
CAH (Cardinal Health) is a large-cap healthcare distributor with durable cash flows and a defensively positioned business model, suggesting the 10.7% pullback from its 30-day high is more likely technical or sector-rotation-driven than fundamental deterioration — especially given the absence of any negative headlines or adverse SEC filings in the window. Today's broad market is constructively positive (SPY +0.79%, VXX -2.54%), which supports risk-on sentiment that could help a healthcare name recover. However, the elevated 5-year breakeven inflation reading (2.7, 2.5σ above trend) introduces margin and cost-of-goods uncertainty for a low-margin distribution business like CAH.
✓May 14, 9:35 PMdecisionacted
Agent 5 — Dip Buyer (Evolving) — decide: buy
CAH (Cardinal Health) is a large-cap healthcare distributor with relatively stable, defensive cash flows and no recent negative news or SEC filings visible in the window to explain the 10.7% pullback from its 30-day high. Today's broad market is firmly positive (SPY +0.79%, QQQ +0.71%, VXX -2.54%), suggesting the drop is not macro-driven panic but likely reflects idiosyncratic selling pressure or sector rotation, which historically tends to mean-revert for fundamentally sound names. The elevated 5-year inflation breakeven (T5YIE at 2.7, 2.5σ above trend) is a mild headwind for defensive healthcare distributors but not a disqualifying factor.
?May 14, 9:34 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
With no headlines or SEC filings in the window, the ~10.7% pullback from the 30-day high appears driven by macro/sector rotation rather than company-specific deterioration. CAH (Cardinal Health) is a large-cap healthcare distributor with relatively stable cash flows and defensive characteristics, suggesting the business fundamentals are likely intact. However, the elevated 5-year inflation breakeven (2.7, 2.5σ above trend) signals a risk-off macro environment that could continue to pressure rate-sensitive and lower-margin distribution businesses, limiting near-term upside.
?May 14, 9:34 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
CAH (Cardinal Health) is a large-cap healthcare distribution company with generally stable fundamentals, but the 10.7% drop from its 30-day high is notable given the absence of any news headlines or recent SEC filings to explain it — this suggests either sector rotation, macro-driven selling, or a catalyst that predates the 30-day window. Today's broad-market tone is constructively bullish (SPY +0.79%, VXX -2.54%), which is modestly supportive of a recovery, but the idiosyncratic nature of a ~11% drawdown without visible news is a yellow flag. The elevated 5-year inflation breakeven (T5YIE at 2.5σ above trend) adds margin pressure uncertainty for a low-margin distributor like CAH.
?May 14, 9:33 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
With no headlines or SEC filings in the window, the ~10.7% pullback from the 30-day high appears driven by macro/sector rotation rather than company-specific deterioration. CAH (Cardinal Health) is a large-cap healthcare distributor with relatively stable cash flows and defensive characteristics, suggesting the business fundamentals are likely intact. However, the elevated 5-year inflation breakeven (2.7, 2.5σ above trend) signals a risk-off macro environment that could continue to pressure rate-sensitive and lower-margin distribution businesses, limiting near-term upside.
?May 14, 9:33 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
CAH (Cardinal Health) is a large-cap healthcare distribution company with generally stable fundamentals, but the 10.7% drop from its 30-day high is notable given the absence of any news headlines or recent SEC filings to explain it — this suggests either sector rotation, macro-driven selling, or a catalyst that predates the 30-day window. Today's broad-market tone is constructively bullish (SPY +0.79%, VXX -2.54%), which is modestly supportive of a recovery, but the idiosyncratic nature of a ~11% drawdown without visible news is a yellow flag. The elevated 5-year inflation breakeven (T5YIE at 2.5σ above trend) adds margin pressure uncertainty for a low-margin distributor like CAH.
?May 14, 9:26 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
With no headlines or SEC filings in the window, the ~10.7% pullback from the 30-day high appears driven by macro/sector rotation rather than company-specific deterioration. CAH (Cardinal Health) is a large-cap healthcare distributor with relatively stable cash flows and defensive characteristics, suggesting the business fundamentals are likely intact. However, the elevated 5-year inflation breakeven (2.7, 2.5σ above trend) signals a risk-off macro environment that could continue to pressure rate-sensitive and lower-margin distribution businesses, limiting near-term upside.
?May 14, 9:24 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
CAH (Cardinal Health) is a large-cap healthcare distribution company with generally stable fundamentals, but the 10.7% drop from its 30-day high is notable given the absence of any news headlines or recent SEC filings to explain it — this suggests either sector rotation, macro-driven selling, or a catalyst that predates the 30-day window. Today's broad-market tone is constructively bullish (SPY +0.79%, VXX -2.54%), which is modestly supportive of a recovery, but the idiosyncratic nature of a ~11% drawdown without visible news is a yellow flag. The elevated 5-year inflation breakeven (T5YIE at 2.5σ above trend) adds margin pressure uncertainty for a low-margin distributor like CAH.
▢May 14, 8:00 PMjournal
Agent 7 — Day Trader opened long 10 @ $194.38
▣May 14, 8:00 PMjournaltime_stop
Agent 7 — Day Trader closed long 10 @ $196.08 (+$17.00)
EOD forced close — day trader never carries overnight
▢May 14, 8:00 PMjournal
Agent 5 — Dip Buyer (Evolving) opened long 3 @ $194.38
▢May 14, 8:00 PMjournal
Agent 5 — Dip Buyer (Evolving) opened long 1 @ $194.38
▢May 14, 8:00 PMjournal
Agent 5 — Dip Buyer (Evolving) opened long 1 @ $194.38
▢May 14, 8:00 PMjournal
Agent 5 — Dip Buyer (Evolving) opened long 1 @ $194.38

← Back to dashboard